How Obesity Impacts Lifespan | Longevity, Episode 1

Video Description

In the premiere episode of “Longevity," David Rubenstein explores the ongoing obesity crisis in America, examining its longstanding impact and the latest medical advancements aimed at addressing it, most notably the development of GLP-1s. He also delves into the question of whether weight-loss drugs offer a lasting solution. Guests include: Dave Ricks | Eli Lilly Chair & CEO David Cordani | Cigna Chairman & CEO Dr. Louis Aronne | Director, Comprehensive Weight Control Center at Weill Cornell Medicine Dr. Fatima Cody Stanford | Obesity Specialist, Massachusetts General Hospital and Harvard Medical School Longevity with David Rubenstein dives into the rapidly evolving world of medical research, pharmaceuticals, and science-backed wellness to uncover the facts behind the growing human pursuit of longer, healthier lives. In his new show, Rubenstein speaks with leading scientists, physicians and policy experts to examine one of the most urgent and captivating questions of our time: how can we live longer -- and better? Chapters: 00:00 Longevity 02:26 - Rising Obesity Rate 04:00 Dr. Stanford on BMI 06:30 Do diets really work? 08:30 Dr. Aronne - do GLP-1s work? 11:30 Lilly's weight loss drugs 12:49 - Obesity's Effect on Health / GLP-1s 16:30 How bad is fast food for you? 19:46 - Diet and Exercise -------- Like this video? Subscribe to The David Rubenstein Show on YouTube: https://www.youtube.com/channel/UCqsN9MYiu1mKSAsYoF6ppTg Watch the latest episodes of "The David Rubenstein Show: Peer-to-Peer Conversations" here: https://www.bloomberg.com/peer-to-peer Learn more about David: http://www.davidrubenstein.com/ Connect with us on... Twitter: https://twitter.com/business Facebook: https://www.facebook.com/bloombergbusiness Instagram: https://www.instagram.com/bloombergbusiness/